Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Talis Biomedical Corp (TLIS)

Talis Biomedical Corp (TLIS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Talis Biomedical Corp 1375 WEST FULTON MARKET SUITE 700 CHICAGO IL 60607 USA

https://talisbio.com P: 650-433-3000

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Talis Biomedical Corporation engaged in developing and commercializing products for infectious diseases at the point-of-care. The company involved in developing the Talis One platform, a compact, sample-to-answer, cloud-enabled, molecular diagnostic platform. Talis Biomedical Corporation is based in MENLO PARK, Calif.

Key Statistics

Overview:

Market Capitalization, $K 5,177
Enterprise Value, $K -71,553
Shares Outstanding, K 1,823
Float, K 984
% Float 54.00%
Short Interest, K 4
Short Float 0.23%
Days to Cover 4.87
Short Volume Ratio 0.01
% of Insider Shareholders 46.00%
% of Institutional Shareholders 43.77%

Financials:

Annual Sales, $ 2,130 K
Annual Net Income, $ -62,010 K
Last Quarter Sales, $ 70 K
Last Quarter Net Income, $ -13,040 K
EBIT, $ -61,940 K
EBITDA, $ -61,170 K

Growth:

1-Year Return 54.35%
3-Year Return -71.15%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 10/06/25
Earnings Per Share ttm -31.43
EPS Growth vs. Prev Year -41.56%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 07/06/23

TLIS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -2,911.27%
Debt/Equity 0.00
Price/Sales 26.59
Price/Cash Flow N/A
Price/Book 0.11
Book Value/Share 31.14
Interest Coverage -1.20
60-Month Beta 1.32
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar